Skip to Content

TEVA 5004 (Amlodipine Besylate, Hydrochlorothiazide and Olmesartan Medoxomil 5 mg / 25 mg / 40 mg)

Pill with imprint TEVA 5004 is Yellow, Capsule-shape and has been identified as Amlodipine Besylate, Hydrochlorothiazide and Olmesartan Medoxomil 5 mg / 25 mg / 40 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Amlodipine/hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Amlodipine/hydrochlorothiazide/olmesartan 5 mg / 25 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 5004

Amlodipine besylate, hydrochlorothiazide and olmesartan medoxomil 5 mg / 25 mg / 40 mg TEVA 5004

Amlodipine Besylate, Hydrochlorothiazide and Olmesartan Medoxomil

Imprint
TEVA 5004
Strength
5 mg / 25 mg / 40 mg
Color
Yellow
Size
13.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous antihypertensive combinations
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-5004
Inactive Ingredients
lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 3350, povidone k30, silicon dioxide, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide, D&C Yellow No. 10, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.